Premium
FibroBiologics Inc (FBLG)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company’s product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound... FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company’s product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis. It also develops early-stage research products, including CYTER915 to treat the human longevity; and TCB190 for the treatment of certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0651 | -7.07608695652 | 0.92 | 0.9782 | 0.836 | 67860 | 0.88007658 | CS |
| 4 | -0.0753 | -8.09503332617 | 0.9302 | 1.04 | 0.731 | 197764 | 0.8401056 | CS |
| 12 | -0.5451 | -38.9357142857 | 1.4 | 1.83 | 0.731 | 250416 | 1.12128629 | CS |
| 26 | 0.5065 | 145.378874856 | 0.3484 | 3.965 | 0.185 | 746516 | 0.61486493 | CS |
| 52 | 0.2549 | 42.4833333333 | 0.6 | 3.965 | 0.185 | 1007816 | 0.45657324 | CS |
| 156 | -29.1451 | -97.1503333333 | 30 | 55 | 0.185 | 568980 | 1.26598648 | CS |
| 260 | -29.1451 | -97.1503333333 | 30 | 55 | 0.185 | 568980 | 1.26598648 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
